0000950123-10-035507 Sample Contracts

CONFIDENTIAL TREATMENT REQUESTED LICENSE AND OPTION AGREEMENT between EMORY UNIVERSITY and ALIMERA SCIENCES, INC. for TRIPHENYLMETHANE COMPOUNDS
License and Option Agreement • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia

THIS LICENSE AND OPTION AGREEMENT is made and entered into as of the 31st day of August, 2009, (hereinafter referred to as the “Effective Date”) by and between EMORY UNIVERSITY, a nonprofit Georgia corporation with offices located at 1599 Clifton Road NE, 4th Floor, Atlanta, Georgia 30322 (hereinafter referred to as “EMORY”) and Alimera Sciences, Inc., a Delaware corporation having a principal place of business located at 6120 Windward Parkway, Suite 290, Alpharetta, Georgia 30024 (hereinafter referred to as “ALIMERA”).

Sample 1Sample 2
AutoNDA by SimpleDocs
CONFIDENTIAL TREATMENT REQUESTED ASSET PURCHASE AGREEMENT BETWEEN BAUSCH & LOMB INCORPORATED AND ALIMERA SCIENCES, INC. DATED DECEMBER 20, 2006
Asset Purchase Agreement • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations

This Asset Purchase Agreement, dated as of December 20, 2006, is by and between Alimera Sciences, Inc., a Delaware corporation (“Seller”) and Bausch & Lomb Incorporated, a New York corporation (“Buyer”).

Sample 1Sample 2
CONFIDENTIAL TREATMENT REQUESTED LICENSE AND OPTION AGREEMENT between EMORY UNIVERSITY and ALIMERA SCIENCES, INC.
Confidential Treatment Requested • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia

THIS LICENSE AND OPTION AGREEMENT is made and entered into as of the 16th day of July, 2009, (hereinafter referred to as the “Effective Date”) by and between EMORY UNIVERSITY, a nonprofit Georgia corporation with offices located at 1599 Clifton Road NE, 4th Floor, Atlanta, Georgia 30322 (hereinafter referred to as “EMORY”) and Alimera Sciences, Inc., a Delaware corporation having a principal place of business located at 6120 Windward Parkway, Suite 290, Alpharetta, Georgia 30024 (hereinafter referred to as “ALIMERA”).

Sample 1Sample 2
AMENDED AND RESTATED COLLABORATION AGREEMENT BY AND BETWEEN PSIVIDA, INC. (f/k/a CONTROL DELIVERY SYSTEMS, INC.) AND ALIMERA SCIENCES, INC. DATED AS OF MARCH 14, 2008
Collaboration Agreement • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations • Georgia

* Certain information has been omitted and filed separately with the commission. Confidential treatment has been requested with respect to the omitted portions.

Sample 1Sample 2
CONFIDENTIAL TREATMENT REQUESTED License Agreement
License Agreement • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations • New York

This License Agreement (“Agreement”) is made and entered into as of November 4, 2007, by and between Dainippon Sumitomo Pharma Co., Ltd., a corporation having its registered office at 6-8, Doshomachi 2-chome, Chuo-ku, Osaka 541-0045, Japan (“DSP”), and Alimera Sciences, Inc., a corporation having its registered office at 6120 Windward Parkway, Suite 290, Alpharetta, GA 30005, USA (“Alimera”), to confirm the mutual agreement of the parties with respect to certain patent rights as set forth below.

Sample 1Sample 2
CONFIDENTIAL TREATMENT REQUESTED ASSET PURCHASE AGREEMENT BETWEEN BAUSCH & LOMB INCORPORATED AND ALIMERA SCIENCES, INC. DATED FEBRUARY 16, 2007
Confidential Treatment • April 16th, 2010 • Alimera Sciences Inc • Pharmaceutical preparations • New York

This Asset Purchase Agreement, dated as of February 16, 2007, is by and between Alimera Sciences, Inc., a Delaware corporation (“Seller”) and Bausch & Lomb Incorporated, a New York corporation (“Buyer”).

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.